Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Winston Dunn
Is It Worthy of Switching to PegIFN Alfa-2a in Patients Achieving Virological Suppression With Entecavir?
Journal of Hepatology
Hepatology
Related publications
Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Interferon Alfa-2a Is Ineffective for Patients With Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Archives of Ophthalmology
Economic Citizenship: Is It Worthy Investment?
Fiscaoeconomia
Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis
New England Journal of Medicine
Medicine
Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients With a Partial Virological Response
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
Gastroenterology
Hepatology
Gastroenterology
Peginterferon Alfa-2a Is Associated With Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients With Sustained Virologic Response
PLoS ONE
Multidisciplinary
Impact of Pegylated Interferon-Alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study
Hepatitis Monthly
Hepatology
Infectious Diseases
Cost-Effectiveness Analysis of Treatment With Peginterferon-Alfa-2a Versus Peginterferon-Alfa-2b for Patients With Chronic Hepatitis C Under the Public Payer Perspective in Brazil
Cost Effectiveness and Resource Allocation
Health Policy
